Key result
Interspecies electrophysiology differences hinder translation of preclinical arrhythmia models to human therapies.
Answers are grounded in this paper and cite their sources.
Understanding species-specific differences in cardiac electrophysiology is critical for improving the translation of preclinical arrhythmia models to human therapies.
Although ventricular arrhythmia remains a leading cause of morbidity and mortality, available antiarrhythmic drugs have limited efficacy. Disappointing progress in the development of novel, clinically relevant antiarrhythmic agents may partly be attributed to discrepancies between humans and animal models used in preclinical testing. However, such differences are at present difficult to predict, requiring improved understanding of arrhythmia mechanisms across species. To this end, we presently review interspecies similarities and differences in fundamental cardiomyocyte electrophysiology and current understanding of the mechanisms underlying the generation of afterdepolarizations and reentry. We specifically highlight patent shortcomings in small rodents to reproduce cellular and tissue-level arrhythmia substrate believed to be critical in human ventricle. Despite greater ease of translation from larger animal models, discrepancies remain and interpretation can be complicated by incomplete knowledge of human ventricular physiology due to low availability of explanted tissue. We therefore point to the benefits of mathematical modeling as a translational bridge to understanding and treating human arrhythmia.
No takes yet. Share an insight, caveat, or question.
Edwards et al. (2017) conducted a review in Cardiac Arrhythmia. Interspecies differences in cardiomyocyte electrophysiology, particularly in repolarizing potassium currents and calcium handling, complicate the translation of preclinical arrhythmia models to human therapies.
Synapse has enriched 10 related papers. Consider them for comparative context: